Ovarian Cancer: 6 Silent Warning Signs Indian Women Should Know

Ovarian cancer is one of the deadliest gynecological cancers in India. According to NCRP data, approximately 50,000 new cases are diagnosed annually, with majority detected in advanced stages. The cancer develops inside the ovaries, deep in the abdomen, where early symptoms are easy to miss or dismiss as digestive problems.

The ovaries are small and located deep within the pelvis. A tumor can grow significantly before causing noticeable symptoms. By the time women seek help, the cancer has often spread beyond the ovaries to the fallopian tubes, uterus, and peritoneum. Stage 3 or 4 cancers have much lower survival rates than stage 1.

The gap between symptom onset and diagnosis is critical. Many women report that they visited multiple doctors before getting proper investigation. This delay happens because the symptoms mimic common conditions like irritable bowel syndrome, digestive issues, or stress-related problems.

Why Ovarian Cancer Is Called the Silent Killer

Ovarian cancer is one of the deadliest gynecological cancers in India. According to NCRP data, approximately 50,000 new cases are diagnosed annually, with majority detected in advanced stages. The cancer develops inside the ovaries, deep in the abdomen, where early symptoms are easy to miss or dismiss as digestive problems.

The ovaries are small and located deep within the pelvis. A tumor can grow significantly before causing noticeable symptoms. By the time women seek help, the cancer has often spread beyond the ovaries to the fallopian tubes, uterus, and peritoneum. Stage 3 or 4 cancers have much lower survival rates than stage 1.

The gap between symptom onset and diagnosis is critical. Many women report that they visited multiple doctors before getting proper investigation. This delay happens because the symptoms mimic common conditions like irritable bowel syndrome, digestive issues, or stress-related problems.

The 6 Silent Warning Signs You Must Not Ignore

These symptoms are subtle and easy to attribute to other causes. The key is persistence. If any of these continue for more than two to three weeks, medical evaluation is urgent.

• Persistent Bloating: Abdominal bloating that doesn’t improve with dietary changes or gas relief medications is a red flag. Unlike normal bloating that comes and goes, ovarian cancer-related bloating is constant and may worsen throughout the day.
• Pelvic or Lower Abdominal Pain: Cramping, sharp pain, or dull aching in the lower abdomen or pelvis that persists beyond your menstrual cycle requires investigation. Pain during intercourse (dyspareunia) can also be a warning sign.
• Changes in Bowel or Bladder Habits: Sudden constipation that doesn’t respond to dietary fiber, or increased urinary frequency without infection, can indicate abdominal pressure from a tumor.
• Early Satiety: Feeling full quickly when eating, even when hungry, occurs when tumors take up space in the abdomen and compress the stomach.
• Loss of Appetite and Weight Loss: Unexplained weight loss combined with loss of interest in food is concerning. Cancer cells consume energy and interfere with normal metabolism.
• Fatigue and General Malaise: Persistent tiredness that doesn’t improve with rest, combined with a sense of feeling generally unwell, is frequently reported by women with ovarian cancer.

Understanding CA-125: The Tumor Marker

CA-125 is a protein produced by ovarian cancer cells. Blood tests can measure this protein level. Elevated CA-125 doesn’t diagnose cancer by itself, but it’s a useful screening tool, especially for women at high risk. Levels above 35 U/mL warrant further investigation.

However, CA-125 can be elevated in non-cancerous conditions too, such as endometriosis, fibroids, menstruation, and even benign ovarian cysts. This is why doctors never use CA-125 alone for diagnosis. Imaging (ultrasound, CT) combined with blood work provides the complete picture.

For women with a family history of ovarian cancer, regular CA-125 screening combined with transvaginal ultrasound may be recommended. The combination of tests is more reliable than either test alone. Discuss your individual risk with your gynecologist.

Who Is at Higher Risk in India

Family history is the strongest risk factor. If your mother, sister, or daughter has had ovarian cancer, your risk increases significantly. BRCA gene mutations increase risk by 40-45%. Genetic testing is available and should be considered if you have a strong family history.

Age is also a factor. Ovarian cancer risk increases after age 50, though it can occur at any age. Earlier menopause (before age 40) and late menopause (after age 55) also increase risk, likely due to prolonged exposure to estrogen.

Obesity, especially postmenopausal obesity, increases risk. Estrogen produced by fat tissue may promote tumor growth. Similarly, hormone replacement therapy used during menopause slightly increases risk. Nulliparity (never having been pregnant) also increases risk, while multiple pregnancies and breastfeeding reduce it.

Investigation and Diagnosis Process in India

If your doctor suspects ovarian cancer, the first step is typically transvaginal ultrasound. This imaging is more sensitive for ovarian pathology than external ultrasound. The ultrasound technician looks for cystic masses, solid components, and abnormal blood flow patterns.

CT scan or MRI provides additional detail about tumor size, extent, and whether cancer has spread to lymph nodes or other organs. Blood tests measure CA-125 and other tumor markers. These investigations help determine the stage of cancer and guide treatment planning.

Definitive diagnosis requires tissue biopsy, often obtained during surgery. In India, major cancer centers can offer fertility-sparing surgery for young women with early-stage cancer, preserving the ability to have children in the future. This is an important discussion to have with your oncologist.

Risk Reduction and Screening Strategies

Pregnancy and breastfeeding reduce ovarian cancer risk significantly. Each additional pregnancy further lowers risk. Oral contraceptives, when used for several years, also reduce risk by 30-50% compared to women who never used them. This is one of the few modifiable risk factors.

Maintaining a healthy weight, regular physical activity, and a balanced diet may reduce risk. Some studies suggest that increased physical activity reduces risk independent of weight. Managing stress and avoiding smoking are also protective.

For women at very high risk due to BRCA mutations or strong family history, prophylactic salpingo-oophorectomy (removal of fallopian tubes and ovaries) after completing childbearing is an option that dramatically reduces ovarian cancer risk. This decision requires careful counseling about surgical risks and menopause management.

What to Expect After Diagnosis

Treatment typically combines surgery and chemotherapy. Surgery removes the tumor, affected ovary or ovaries, and sometimes the uterus and fallopian tubes. The extent depends on cancer stage and age. Young women with early-stage cancer may have surgery that preserves fertility.

Chemotherapy after surgery targets any remaining cancer cells. Platinum-based drugs (like carboplatin) combined with taxanes (like paclitaxel) are standard. Modern targeted therapies and immunotherapy drugs are increasingly available in India, offering better outcomes with fewer side effects than traditional chemotherapy.

Prognosis depends on stage at diagnosis. Stage 1 cancers (confined to ovaries) have 5-year survival rates of 85-90%. Stage 3 or 4 cancers have much lower survival rates, though newer treatments are improving outcomes. Early detection through awareness and appropriate screening is your best defense.